IP Library Granted Patent US 9,150,045
Granted Patent B2
US 9,150,045 · App. 13/363,097 · Granted Oct 6, 2015

Method and device for surgical marking

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,150,045
App. No.
13/363,097
Granted
Oct 6, 2015
Kind
B2
Abstract

A surgical marking pen may include a pen body, a first chamber within the pen body containing at least one powdered dye, a second chamber within the pen body and separated from the first chamber, and a tip in fluid communication with the first chamber or the second chamber. The second container contains a solvent, and the first chamber and the second chamber are selectively placeable into fluid communication with one another. The at least one powdered dye and the solvent, when mixed, form a dye solution which is disposable upon a skin or tissue surface and is able to be visualized simultaneously by a user in ambient light and with a fluorescence imager.

Claims (42)

1. A surgical marking pen, comprising:

a pen body;

a first chamber within the pen body containing at least one powdered dye;

a second chamber within the pen body and separated from the first chamber, the second container containing a solvent, the first chamber and the second chamber being selectively placeable into fluid communication with one another; and

a tip in fluid communication with the first chamber or the second chamber,

wherein the at least one powdered dye and the solvent, when mixed, form a dye solution which is disposable upon a skin or tissue surface and is able to be visualized simultaneously by a user in ambient light and with a fluorescence imager.

2. The pen of claim 1 , further comprising a filter between the tip and the first chamber or the second chamber, the filter being configured to homogenize the dye solution and to filter any particulates before the dye solution enters the tip.

3. The pen of claim 2 , wherein the filter comprises a plurality of pores having a size between 5 and 100 microns.

4. The pen of claim 1 , wherein the at least one powdered dye contains one or more dyes visible upon the skin or tissue surface in ambient light.

5. The pen of claim 4 , wherein the at least one powdered dye is selected from the group consisting of gentian violet, bonnie's blue, brilliant green, silver nitrate, aniline dye, and combinations thereof.

6. The pen of claim 1 , wherein the at least one powdered dye comprises one or more invisible fluorescing dyes.

7. The pen of claim 6 , wherein the one or more invisible fluorescing dyes is selected from the group consisting of cyanine, phthalocyanine, oxazine, rhodamine dye, and combinations thereof.

8. The pen of claim 1 , wherein the pen is sterile.

9. The pen of claim 1 , wherein the pen body and/or a cap for receiving the pen body is marked with a scale.

10. A surgical procedure kit, comprising:

the pen as in claim 1 ; and

a volume of intravenous ICG.

11. The kit of claim 10 , further comprising at least one surgical drape.

12. The kit of claim 10 , further comprising a measuring device comprising a scale or a caliper.

13. The kit of claim 10 , further comprising an infrared fluoroscope.

14. The pen of claim 1 , wherein the first chamber is configured to maintain the at least one powdered dye in a shelf-life safe condition until the at least one powdered dye is mixed with the solvent.

15. A surgical marking pen, comprising:

a pen body;

a first chamber within the pen body containing at least one fluorescing dye;

a second chamber within the pen body and separated from the first chamber, the second container containing a solvent, the first chamber and the second chamber being selectively placeable into fluid communication with one another; and

a tip in fluid communication with the first chamber or the second chamber, wherein

the first chamber is configured to maintain the at least one fluorescing dye in a shelf-life safe condition until the at least one fluorescing dye is mixed with the solvent, and

the at least one fluorescing dye and the solvent, when mixed, form a dye solution which is disposable upon a skin or tissue surface and is able to be visualized simultaneously by a user in ambient light and with a fluorescence imager.

16. The pen of claim 15 , further comprising a filter between the tip and the first chamber or the second chamber, the filter being configured to homogenize the dye solution and to filter any particulates before the dye solution enters the tip.

17. The pen of claim 16 , wherein the filter comprises a plurality of pores having a size between 5 and 100 microns.

18. The pen of claim 15 , wherein the at least one fluorescing dye contains one or more dyes visible upon the skin or tissue surface in ambient light.

19. The pen of claim 18 , wherein the one or more dyes visible upon the skin or tissue surface is selected from the group consisting of gentian violet, bonnie's blue, brilliant green, silver nitrate, aniline dye, and combinations thereof.

20. The pen of claim 15 , wherein the at least one fluorescing dye comprises one or more invisible fluorescing dyes.

21. The pen of claim 20 , wherein the one or more invisible fluorescing dyes is selected from the group consisting of cyanine, phthalocyanine, oxazine, rhodamine dye, and combinations thereof.

22. The pen of claim 15 , wherein the pen is sterile.

23. The pen of claim 15 , wherein the pen body and/or a cap for receiving the pen body is marked with a scale.

24. A surgical procedure kit, comprising:

the pen as in claim 15 ; and

a volume of intravenous ICG.

25. The pen of claim 15 , wherein the at least one fluorescing dye is a powdered dye.

26. The pen of claim 15 , wherein the solvent comprises at least one dye visible in ambient light.

27. The pen of claim 1 , wherein the solvent comprises at least one dye visible in ambient light.

Assignments (19)
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICATION NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 044910 FRAME: 0507. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER AND CHANGE OF NAME. Recorded May 3, 2021
From: NOVADAQ TECHNOLOGIES INC.
To: NOVADAQ TECHNOLOGIES ULC
Reel/Frame 056425/0530 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICATION NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 052860 FRAME: 0900. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE 12/31/2018. Recorded May 3, 2021
From: STRYKER EUROPEAN HOLDINGS LLC
To: STRYKER EUROPEAN OPERATIONS LIMITED
Reel/Frame 056426/0585 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICATION NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 053823 FRAME: 0445. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE 11/29/2018. Recorded May 3, 2021
From: STRYKER EUROPEAN HOLDINGS III, LLC
To: STRYKER EUROPEAN HOLDINGS LLC
Reel/Frame 056426/0496 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICATION NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 052873 FRAME: 0597. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE 09/05/2018. Recorded May 3, 2021
From: STRYKER EUROPEAN HOLDINGS IV, LLC
To: STRYKER EUROPEAN HOLDINGS III, LLC
Reel/Frame 056426/0352 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICAITON NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 053318 FRAME: 0612. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE 09/05/2018. Recorded May 3, 2021
From: STRYKER EUROPEAN HOLDINGS I, LLC
To: STRYKER EUROPEAN HOLDINGS IV, LLC
Reel/Frame 056425/0731 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICATION NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 052873 FRAME: 0548. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE 11/30/2017. Recorded May 3, 2021
From: NOVADAQ TECHNOLOGIES ULC
To: STRYKER EUROPEAN HOLDINGS I, LLC
Reel/Frame 056425/0616 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 7, 2020
From: NOVADAQ TECHNOLOGIES ULC
To: STRYKER EUROPEAN HOLDINGS I, LLC
Reel/Frame 052873/0548 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 7, 2020
From: STRYKER EUROPEAN HOLDINGS LLC
To: STRYKER EUROPEAN OPERATIONS LIMITED
Reel/Frame 052860/0900 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 7, 2020
From: STRYKER EUROPEAN HOLDINGS IV, LLC
To: STRYKER EUROPEAN HOLDINGS III, LLC
Reel/Frame 052873/0597 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 7, 2020
From: STRYKER EUROPEAN HOLDINGS I, LLC
To: STRYKER EUROPEAN HOLDINGS IV, LLC
Reel/Frame 053318/0612 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 7, 2020
From: STRYKER EUROPEAN HOLDINGS III, LLC
To: STRYKER EUROPEAN HOLDINGS LLC
Reel/Frame 053823/0445 →
MERGER AND CHANGE OF NAME Recorded Dec 19, 2017
From: NOVADAQ TECHNOLOGIES INC.; STRYKER CANADA OPERATIONS ULC
To: NOVADAQ TECHNOLOGIES ULC
Reel/Frame 044910/0507 →
RELEASE OF SECURITY INTEREST Recorded Sep 8, 2017
From: MIDCAP FUNDING IV TRUST (AS SUCCESSOR AGENT TO MIDCAP FINANCIAL TRUST)
To: NOVADAQ TECHNOLOGIES INC.; NOVADAQ CORP.
Reel/Frame 043786/0344 →
RELEASE OF SECURITY INTEREST Recorded Sep 8, 2017
From: MIDCAP FINANCIAL TRUST
To: NOVADAQ TECHNOLOGIES INC.; NOVADAQ CORP.
Reel/Frame 043788/0799 →
SECURITY AGREEMENT (REVOLVING) Recorded Jan 9, 2017
From: NOVADAQ TECHNOLOGIES; NOVADAQ CORP.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 041306/0172 →
SECURITY AGREEMENT (TERM) Recorded Jan 9, 2017
From: NOVADAQ TECHNOLOGIES; NOVADAQ CORP.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 041306/0189 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 30, 2013
From: ICG MARKER, LLC
To: NOVADAQ TECHNOLOGIES, INC.
Reel/Frame 030906/0766 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 30, 2013
From: TAUTONA GROUP RESEARCH AND DEVELOPMENT COMPANY, L.L.C.
To: ICG MARKER, LLC
Reel/Frame 030920/0487 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 13, 2012
From: GURTNER, GEOFFREY C.; RIMSA, JOSEPH
To: TAUTONA GROUP RESEARCH AND DEVELOPMENT COMPANY, L.L.C.
Reel/Frame 028044/0570 →